ID   Pro104.D9.1
AC   CVCL_A0CJ
SY   Pro104D9.1; D9.1
DR   ATCC; PTA-6077
DR   Wikidata; Q108821147
RX   Patent=US8080650;
RX   PubMed=32511276;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6077.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9Y6M0; Human PRSS21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
RX   Patent=US8080650;
RA   Papkoff J., Pilkington G., Keller G.-A., Li W.-L., Corral L.,
RA   Simon I., Kmet M., Tang J.-W.;
RT   "Pro104 antibody compositions and methods of use.";
RL   Patent number US8080650, 20-Dec-2011.
//
RX   PubMed=32511276; DOI=10.1371/journal.pone.0234407;
RA   Peroutka R.J. III, Buzza M.S., Mukhopadhyay S., Johnson T.A.,
RA   Driesbaugh K.H., Antalis T.M.;
RT   "Testisin/Prss21 deficiency causes increased vascular permeability and
RT   a hemorrhagic phenotype during luteal angiogenesis.";
RL   PLoS ONE 15:E0234407-E0234407(2020).
//